logo

Genesis Healthcare Inc. (GEN)



Trade GEN now with
  Date
  Headline
11/21/2017 6:59:49 AM Genmab Reports European Regulatory Submission For Daratumumab In Front Line Multiple Myeloma
11/16/2017 9:33:59 PM Genmab Says Achieves $50 Mln Sales Milestone In DARZALEX Collaboration With Janssen
11/8/2017 4:24:14 PM Genesis HealthCare Q3 Loss/share $3.94 Vs. Loss $0.23 Year Ago
11/8/2017 11:06:48 AM Genmab Posts Nine-months Revenue Of DKK 1.35 Bln
10/17/2017 6:53:50 AM Genmab Posts Q3 Net Sales Of DARZALEX $317 Mln
9/27/2017 1:51:37 AM Genmab Reports Approval Of DARZALEX For Relapsed Or Refractory Multiple Myeloma In Japan
8/24/2017 9:25:42 AM Genmab Reports Positive Topline Results In Phase III ALCYONE Study Of Daratumumab In Front Line Multiple Myeloma
8/10/2017 7:27:39 AM RBC Capital Markets Is Lowering Genesis Healthcare Inc. (GEN) 4Q17 Rev. Estimate To 1355.8 M From 1366.1 M
8/10/2017 7:27:26 AM RBC Capital Markets Is Lowering Genesis Healthcare Inc. (GEN) 3Q17 Rev. Estimate To 1336.1 M From 1373.7 M
8/10/2017 7:27:05 AM RBC Capital Markets Is Increasing Genesis Healthcare Inc. (GEN) 2018 Estimate To -0.18 From -0.35
8/10/2017 7:26:52 AM RBC Capital Markets Is Increasing Genesis Healthcare Inc. (GEN) 2017 Estimate To -0.34 From -0.66
8/10/2017 7:26:22 AM RBC Capital Markets Is Raising Genesis Healthcare Inc. (GEN) 2018 Rev. Estimate To 5392.9 M From 5392.7 M
8/10/2017 7:25:08 AM RBC Capital Markets Is Lowering Genesis Healthcare Inc. (GEN) 2017 Rev. Estimate To 5422.4 M From 5449.9 M
8/9/2017 11:27:25 AM Genmab Reports First Half 2017 Revenues Of DKK 1.024 Bln